vs
Side-by-side financial comparison of Blue Bird Corp (BLBD) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $333.1M, roughly 1.5× Blue Bird Corp). Blue Bird Corp runs the higher net margin — 9.2% vs 6.8%, a 2.4% gap on every dollar of revenue. On growth, Blue Bird Corp posted the faster year-over-year revenue change (6.1% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.9%).
The Blue Bird Corporation is an American bus manufacturer. Headquartered in Fort Valley, Georgia, the company was best known for its production of school buses. The company has also manufactured a wide variety of other bus types, including transit buses, motorhomes, and specialty vehicles such as mobile libraries and mobile police command centers.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BLBD vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $333.1M | $493.8M |
| Net Profit | $30.8M | $33.7M |
| Gross Margin | 21.4% | — |
| Operating Margin | 11.3% | 9.9% |
| Net Margin | 9.2% | 6.8% |
| Revenue YoY | 6.1% | -1.7% |
| Net Profit YoY | 7.1% | 10.5% |
| EPS (diluted) | $0.94 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $333.1M | $493.8M | ||
| Q3 25 | $409.4M | $492.9M | ||
| Q2 25 | $398.0M | $468.8M | ||
| Q1 25 | $358.9M | $458.4M | ||
| Q4 24 | $313.9M | $502.4M | ||
| Q3 24 | $350.2M | $511.2M | ||
| Q2 24 | $333.4M | $504.3M | ||
| Q1 24 | $345.9M | $495.1M |
| Q4 25 | $30.8M | $33.7M | ||
| Q3 25 | $36.5M | $71.7M | ||
| Q2 25 | $36.5M | $39.3M | ||
| Q1 25 | $26.0M | $20.7M | ||
| Q4 24 | $28.7M | $30.5M | ||
| Q3 24 | $24.7M | $19.4M | ||
| Q2 24 | $28.7M | $-153.0M | ||
| Q1 24 | $26.0M | $4.0M |
| Q4 25 | 21.4% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 21.6% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 17.0% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 18.4% | — |
| Q4 25 | 11.3% | 9.9% | ||
| Q3 25 | 12.3% | 13.8% | ||
| Q2 25 | 12.6% | 12.8% | ||
| Q1 25 | 9.4% | 7.0% | ||
| Q4 24 | 10.5% | 7.8% | ||
| Q3 24 | 7.3% | 6.6% | ||
| Q2 24 | 11.9% | -31.3% | ||
| Q1 24 | 10.4% | 3.2% |
| Q4 25 | 9.2% | 6.8% | ||
| Q3 25 | 8.9% | 14.5% | ||
| Q2 25 | 9.2% | 8.4% | ||
| Q1 25 | 7.3% | 4.5% | ||
| Q4 24 | 9.2% | 6.1% | ||
| Q3 24 | 7.0% | 3.8% | ||
| Q2 24 | 8.6% | -30.3% | ||
| Q1 24 | 7.5% | 0.8% |
| Q4 25 | $0.94 | $0.40 | ||
| Q3 25 | $1.11 | $0.84 | ||
| Q2 25 | $1.12 | $0.46 | ||
| Q1 25 | $0.79 | $0.24 | ||
| Q4 24 | $0.86 | $0.37 | ||
| Q3 24 | $0.71 | $0.23 | ||
| Q2 24 | $0.85 | $-1.84 | ||
| Q1 24 | $0.79 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $241.7M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $271.4M | $865.9M |
| Total Assets | $642.3M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $241.7M | $375.2M | ||
| Q3 25 | $229.3M | $340.1M | ||
| Q2 25 | $173.1M | $224.7M | ||
| Q1 25 | $130.7M | $99.0M | ||
| Q4 24 | $136.1M | $229.9M | ||
| Q3 24 | $127.7M | $103.8M | ||
| Q2 24 | $88.4M | $19.4M | ||
| Q1 24 | $93.1M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $271.4M | $865.9M | ||
| Q3 25 | $255.4M | $890.7M | ||
| Q2 25 | $221.8M | $833.8M | ||
| Q1 25 | $190.4M | $789.2M | ||
| Q4 24 | $179.7M | $764.9M | ||
| Q3 24 | $159.6M | $732.5M | ||
| Q2 24 | $137.3M | $706.5M | ||
| Q1 24 | $105.8M | $856.2M |
| Q4 25 | $642.3M | $2.2B | ||
| Q3 25 | $625.3M | $2.2B | ||
| Q2 25 | $575.5M | $2.1B | ||
| Q1 25 | $543.7M | $2.0B | ||
| Q4 24 | $535.2M | $2.2B | ||
| Q3 24 | $524.9M | $2.1B | ||
| Q2 24 | $468.1M | $2.0B | ||
| Q1 24 | $456.5M | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.6M | $114.1M |
| Free Cash FlowOCF − Capex | $31.1M | — |
| FCF MarginFCF / Revenue | 9.3% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 1.19× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $162.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.6M | $114.1M | ||
| Q3 25 | $65.1M | $137.3M | ||
| Q2 25 | $56.9M | $137.2M | ||
| Q1 25 | $27.8M | $-117.5M | ||
| Q4 24 | $26.4M | $133.0M | ||
| Q3 24 | $55.4M | $91.8M | ||
| Q2 24 | $989.0K | $107.0M | ||
| Q1 24 | $54.6M | $-125.2M |
| Q4 25 | $31.1M | — | ||
| Q3 25 | $60.5M | — | ||
| Q2 25 | $52.3M | — | ||
| Q1 25 | $18.7M | — | ||
| Q4 24 | $21.8M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $51.8M | — |
| Q4 25 | 9.3% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | 15.0% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 1.19× | 3.39× | ||
| Q3 25 | 1.78× | 1.91× | ||
| Q2 25 | 1.56× | 3.49× | ||
| Q1 25 | 1.07× | -5.66× | ||
| Q4 24 | 0.92× | 4.36× | ||
| Q3 24 | 2.24× | 4.72× | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 2.10× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLBD
| Alternative Fuel Buses | $151.4M | 45% |
| Diesel Buses | $144.9M | 43% |
| Parts | $24.8M | 7% |
| Other | $12.1M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
